China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Consistency comparison of PD-L1 antibody reagents WD160 and 22C3'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136755

Registration Time: 2026/11/15

Type: Observational study

Primary Sponsor: Zhejiang Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=328415

Published by HT Digital Content Services with permission from Health Daily Digest....